{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:16:26Z","timestamp":1776291386025,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2024-1G-4023"],"award-info":[{"award-number":["2024-1G-4023"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["19-007\/1792"],"award-info":[{"award-number":["19-007\/1792"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Cancer Center"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jncc.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:54:03Z","timestamp":1753919643000},"page":"493-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Score-based prediction model for female hepatocellular carcinoma surveillance in asymptotic HBsAg carriers: a multicenter cohort study in China"],"prefix":"10.1016","volume":"5","author":[{"given":"Mengdi","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maomao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changfa","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuopei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1159-1884","authenticated-orcid":false,"given":"Wanqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jncc.2025.05.005_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jncc.2025.05.005_bib0002","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"10417","key":"10.1016\/j.jncc.2025.05.005_bib0003","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)01701-4","article-title":"Women, power, and cancer: a Lancet Commission","volume":"402","author":"Ginsburg","year":"2023","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.jncc.2025.05.005_bib0004","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/carcin\/bgz107","article-title":"Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause","volume":"40","author":"Lee","year":"2019","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.jncc.2025.05.005_bib0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cncr.11528","article-title":"The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma","volume":"98","author":"Iavarone","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.jncc.2025.05.005_bib0006","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/vaccines9080838","article-title":"Gender disparity in host responses to hepatitis B-related hepatocellular carcinoma: a case series","volume":"9","author":"Bashir Hamidu","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jncc.2025.05.005_bib0007","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhep.2023.02.022","article-title":"International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance","volume":"79","author":"Singal","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jncc.2025.05.005_bib0008","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jncc.2025.05.005_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/jiz477","article-title":"Real-world effectiveness from the Asia Pacific Rim Liver Consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients treated with oral antiviral therapy","volume":"221","author":"Yang","year":"2020","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.jncc.2025.05.005_bib0010","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2009.27.4456","article-title":"Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"28","author":"Yang","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jncc.2025.05.005_bib0011","first-page":"679","article-title":"Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends","author":"Cao","year":"2024","journal-title":"Cancer Biol Med"},{"issue":"7","key":"10.1016\/j.jncc.2025.05.005_bib0012","first-page":"715","article-title":"Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups","volume":"114","author":"Saxena","year":"1990","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.jncc.2025.05.005_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG Clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jncc.2025.05.005_bib0014","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.14218\/JCTH.2023.00087","article-title":"Hepatocellular carcinoma risk scores from modeling to real clinical practice in areas highly endemic for hepatitis B infection","volume":"11","author":"Hao","year":"2023","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"10.1016\/j.jncc.2025.05.005_bib0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jncc.2025.05.005_bib0016","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jncc.2025.05.005_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/cld.761","article-title":"Surveillance and diagnosis of hepatocellular carcinoma","volume":"13","author":"Lim","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"2","key":"10.1016\/j.jncc.2025.05.005_bib0018","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(18)30488-1","article-title":"Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.jncc.2025.05.005_bib0019","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"issue":"9","key":"10.1016\/j.jncc.2025.05.005_bib0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s43018-023-00618-8","article-title":"Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study","volume":"4","author":"Zeng","year":"2023","journal-title":"Nat Cancer"},{"issue":"12","key":"10.1016\/j.jncc.2025.05.005_bib0021","first-page":"886","article-title":"Bureau of Medical Administration & National Health and Family Planning Commission of the People\u2019s Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)","volume":"25","year":"2017","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.jncc.2025.05.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jncc.2025.05.005_bib0023","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-med.2024.100105","article-title":"Twelve practical recommendations for developing and applying clinical predictive models","volume":"2","author":"Feng","year":"2024","journal-title":"Innov Med"},{"issue":"2","key":"10.1016\/j.jncc.2025.05.005_bib0024","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.33208","article-title":"Selection of high-risk individuals for esophageal cancer screening: a prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China","volume":"148","author":"Chen","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.jncc.2025.05.005_bib0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21147\/j.issn.1000-9604.2021.03.07","article-title":"A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers","volume":"33","author":"Wang","year":"2021","journal-title":"Chin J Cancer Res"},{"issue":"14","key":"10.1016\/j.jncc.2025.05.005_bib0026","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: users' guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jncc.2025.05.005_bib0027","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"issue":"54","key":"10.1016\/j.jncc.2025.05.005_bib0028","doi-asserted-by":"crossref","first-page":"92431","DOI":"10.18632\/oncotarget.21369","article-title":"Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jncc.2025.05.005_bib0029","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jncc.2025.05.005_bib0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gutjnl-2015-310818","article-title":"Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B","volume":"65","author":"Poh","year":"2016","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jncc.2025.05.005_bib0031","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3350\/cmh.2016.0086","article-title":"Risk score model for the development of hepatocellular carcinoma in treatment-na\u00efve patients receiving oral antiviral treatment for chronic hepatitis B","volume":"23","author":"Sohn","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"10.1016\/j.jncc.2025.05.005_bib0032","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/MEG.0000000000001357","article-title":"Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir\/tenofovir","volume":"31","author":"Yu","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jncc.2025.05.005_bib0033","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2018.02.032","article-title":"Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B","volume":"69","author":"Hsu","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jncc.2025.05.005_bib0034","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/gutjnl-2018-316525","article-title":"A simple AGED score for risk classification of primary liver cancer: development and validation with long-term prospective HBsAg-positive cohorts in Qidong, China","volume":"68","author":"Fan","year":"2019","journal-title":"Gut"},{"issue":"20","key":"10.1016\/j.jncc.2025.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/jnci\/djs372","article-title":"Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases","volume":"104","author":"Wen","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jncc.2025.05.005_bib0036","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"}],"container-title":["Journal of the National Cancer Center"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005425000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005425000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:47:44Z","timestamp":1772920064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667005425000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2667005425000845"],"URL":"https:\/\/doi.org\/10.1016\/j.jncc.2025.05.005","relation":{},"ISSN":["2667-0054"],"issn-type":[{"value":"2667-0054","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Score-based prediction model for female hepatocellular carcinoma surveillance in asymptotic HBsAg carriers: a multicenter cohort study in China","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Cancer Center","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jncc.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Chinese National Cancer Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}